oxazolidin-2-one has been researched along with Clostridioides difficile Infection in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 15 (78.95) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, R; Li, J; Schwarz, S; Tao, J; Walsh, TR; Wang, Y; Wu, C; Zhang, S; Zhou, Y | 1 |
| Birchall, S; Corbett, D; Locher, HH; Skinner, K; Thommes, P | 1 |
| Guery, B | 1 |
| Buitrago, M; Cornely, OA; Gerding, DN; Gheorghe Diaconescu, I; Grill, S; Kracker, H; Louie, TJ; Marrast, AC; Murta de Oliveira, C; Nord, CE; Preotescu, L; Pullman, J; Talbot, GH; Wilcox, MH | 1 |
| Boehringer, D; Bur, D; Caspers, P; Leibundgut, M; Locher, HH; Ritz, D; Rueedi, G; Scaiola, A | 1 |
| Albert, E; Ali, N; Muhammad, A; Rawish, F; Sabih, R; Simcha, W | 1 |
| Athanasiou, A; Baines, SD; Chilton, CH; Crowther, GS; Freeman, J; Locher, HH; Todhunter, SL; Wilcox, MH | 1 |
| Chen, X; Enderlin, M; Fournier, E; Hubschwerlen, C; Keck, W; Kelly, CP; Klenk, A; Locher, HH; Pfaff, P; Ritz, D; Schroeder, S; Seiler, P | 1 |
| Buitrago, M; Charef, P; Cornely, OA; Gerding, DN; Kracker, H; Louie, T; Nord, CE; Talbot, GH; Wilcox, M | 1 |
| Desnica, B; Dingemanse, J; Gehin, M | 1 |
| Best, E; Buitrago, M; Charef, P; Cornely, OA; Gerding, DN; Hecht, DW; Kracker, H; Locher, HH; Louie, T; Nord, CE; Osmolski, JR; Sambol, S; Talbot, GH; Wilcox, M | 1 |
| Martin, J; Wilcox, M | 1 |
| Alam, MJ; Bassères, E; Dotson, KM; Endres, BT; Garey, KW | 1 |
| Alam, MJ; Bassères, E; Endres, BT; Garey, KW | 1 |
| Barman, TK; Bhatnagar, PK; Das, B; Kalia, V; Kumar, GR; Kumar, M; Mathur, T; Raj, VS; Singhal, S; Upadhyay, DJ | 1 |
| Baines, SD; Freeman, J; Hobbs, JK; Huscroft, GS; Lovering, AM; Noel, AR; O'Connor, R; Todhunter, SL; Wilcox, MH | 1 |
| Alcalá, L; Bouza, E; Giannella, M; Marin, M; Muñoz, P; Pedromingo, M; Peláez, T; Valerio, M | 1 |
| Carlier, JP; Courcol, RJ; Loïez, C; Manich, M; Migaud, H | 1 |
| Gottlieb, T; Leroi, MJ; Siarakas, S | 1 |
4 review(s) available for oxazolidin-2-one and Clostridioides difficile Infection
| Article | Year |
|---|---|
Cadazolid vs Vancomycin for the Treatment of Clostridioides difficile Infection: Systematic Review with Meta-analysis.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Oxazolidinones; Randomized Controlled Trials as Topic; Vancomycin | 2020 |
New and emerging therapies for Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Benzimidazoles; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Humans; Lipopeptides; Oxazolidinones; Peptides, Cyclic; Pyridines; Recurrence; Secondary Prevention | 2016 |
Novel antibiotics in development to treat Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Benzimidazoles; Benzopyrans; Clinical Trials as Topic; Clostridium Infections; Depsipeptides; Humans; Lipopeptides; Oxazolidinones; Peptides, Cyclic; Pyridines; Thiazoles; Thiophenes | 2017 |
Cadazolid for the treatment of Clostridium difficile.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Lipopeptides; Oxazolidinones; Peptides, Cyclic; Treatment Outcome | 2017 |
3 trial(s) available for oxazolidin-2-one and Clostridioides difficile Infection
| Article | Year |
|---|---|
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Oxazolidinones; Patient Safety; Recurrence; Vancomycin | 2015 |
Minimal systemic and high faecal exposure to cadazolid in patients with severe Clostridium difficile infection.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug-Related Side Effects and Adverse Reactions; Feces; Female; Humans; Male; Middle Aged; Oxazolidinones; Plasma; Time Factors; Young Adult | 2015 |
Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Ribotyping; Vancomycin; Young Adult | 2016 |
12 other study(ies) available for oxazolidin-2-one and Clostridioides difficile Infection
| Article | Year |
|---|---|
Mobile oxazolidinone/phenicol resistance gene optrA in chicken Clostridium perfringens.
Topics: Animals; Chickens; Clostridium Infections; Clostridium perfringens; Drug Resistance, Bacterial; Oxazolidinones; Thiamphenicol | 2020 |
Time-kill kinetics of cadazolid and comparator antibacterial agents against different ribotypes of Clostridium difficile.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Kinetics; Microbial Sensitivity Tests; Oxazolidinones; Ribotyping; Vancomycin | 2018 |
Clostridium difficile infection trials: what is the primary endpoint?
Topics: Clostridioides difficile; Clostridium Infections; Double-Blind Method; Enterocolitis, Pseudomembranous; Humans; Oxazolidinones | 2019 |
Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Oxazolidinones; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2019 |
Structural basis of translation inhibition by cadazolid, a novel quinoxolidinone antibiotic.
Topics: Acetamides; Anti-Bacterial Agents; Clostridium Infections; Cryoelectron Microscopy; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Oxazolidinones; Peptidyl Transferases; Protein Synthesis Inhibitors; Ribosomes; RNA, Transfer, Met; Staphylococcus aureus | 2019 |
In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection.
Topics: Bacterial Load; Clostridioides difficile; Clostridium Infections; Gastrointestinal Tract; Humans; Microbial Sensitivity Tests; Microbial Viability; Models, Theoretical; Oxazolidinones; Treatment Outcome | 2014 |
In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Fluoroquinolones; Humans; Linezolid; Male; Metronidazole; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Spores, Bacterial; Survival Analysis; Vancomycin | 2014 |
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cricetinae; Disease Models, Animal; Humans; Mesocricetus; Metronidazole; Oxazolidinones; Spores, Bacterial; Vancomycin | 2011 |
Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model.
Topics: Acetamides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Gastrointestinal Tract; Humans; In Vitro Techniques; Linezolid; Metronidazole; Microbial Sensitivity Tests; Oxazolidinones | 2011 |
Potential protective role of linezolid against Clostridium difficile infection.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Cross Infection; Diarrhea; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Ventilator-Associated; Retrospective Studies; Spain; Treatment Outcome | 2012 |
First isolation of Clostridium amygdalinum from a patient with chronic osteitis.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Chronic Disease; Clostridium; Clostridium Infections; Humans; Linezolid; Male; Molecular Sequence Data; Osteitis; Oxazolidinones; Phylogeny | 2006 |
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin | 2002 |